Put Forth Anti-tumor Activity Against PC-3 Prostate Cancer Cells Via Inhibition of Jak-1/STAT-3 Activity

Overview

Journal Saudi J Biol Sci

Specialty Biology

Date 2020 Sep 30

PMID 32994721

Citations 8

Authors

Xiaoming Wang

Bo Wang

Liquan Zhou

Xiang Wang

Vishnu Priya Veeraraghavan

Surapaneni Krishna Mohan

Feng Xin

Affiliations

Soon will be listed here.

Abstract

Background: Prostate cancer (PCA) is a frequent cancer that mainly affects the men. Studying growth feature pathways modified during PCA development may facilitate researchers to expand embattled therapeutic strategies for prostate cancer. In present study, we examined the anticancer potentials of against the prostate cancer (PC-3) cells by inflection of JAK-1/STAT-3 signalling pathway.

Methods: The cytotoxicity of against the PC-3 cells was examined by MTT assay. The ROS production was monitored by using DCFH-DA staining. The apoptotic morphological alterations stimulatory potential of on PC-3 cells was inspected through the dual staining. The expression of Bcl-2, JAK-1, STAT3, Bax and CyclinD1 proteins were measured by western blotting. The caspase-3 and 9 functions were condensed by assay kit.

Results: Findings demonstrates the convince cytotoxicity, accretion of ROS, and apoptosis stimulation in PC-3 cells. In addition, signal transducer and activating transcription (STAT-3) is a successive oncogenic transcriptional factor that regularizes multiplication and apoptosis in cells. Discretion of STAT-3 transcription deliberated as original approach to hinder prostate cell growth. In present exploration, we ascertain that hold back STAT-3 translocation, in that way dropping the eminent expression of, BCL-2, cyclin-D1 and declined the Bax, caspase-3 and 9 expressions in PC-3 cells.

Conclusion: In the end our finding concluded that hinder prostate cell development and convinces apoptosis via hampering the translocation STAT-3.

Citing Articles

Bioactivities and industrial standardization status of : A comprehensive review.

Wu P, Zhang C, Yin Y, Zhang X, Li Q, Yuan L Heliyon. 2024; 10(19):e36987.

PMID: 39435114 PMC: 11492437. DOI: 10.1016/j.heliyon.2024.e36987.

Optimization of chemical conditions for metabolites production by using response surface methodology and investigation of antimicrobial as well as anticancer activities.

Tajik A, Samadlouie H, Salek Farrokhi A, Ghasemi A Front Microbiol. 2024; 14:1280405.

PMID: 38318131 PMC: 10839005. DOI: 10.3389/fmicb.2023.1280405.

Natural Bio-Compounds from and Their Beneficial Biological Actions for Anticancer Application: A Review.

Cadar E, Negreanu-Pirjol T, Pascale C, Sirbu R, Prasacu I, Negreanu-Pirjol B Antioxidants (Basel). 2023; 12(11).

PMID: 38001761 PMC: 10669212. DOI: 10.3390/antiox12111907.

The effect of Ganoderma lucidum polysaccharide extract on sensitizing prostate cancer cells to flutamide and docetaxel: an in vitro study.

Rahimnia R, Akbari M, Yasseri A, Taheri D, Mirzaei A, Ghajar H Sci Rep. 2023; 13(1):18940.

PMID: 37919464 PMC: 10622576. DOI: 10.1038/s41598-023-46118-8.

Effect of Methyl Jasmonate Elicitation on Triterpene Production and Evaluation of Cytotoxic Activity of Mycelial Culture Extracts of (Pers.) Pat.

Sulkowska-Ziaja K, Galanty A, Szewczyk A, Pasko P, Kala K, Apola A Plants (Basel). 2023; 12(2).

PMID: 36679006 PMC: 9867392. DOI: 10.3390/plants12020294.

References

Haugen B . Management of the patient with progressive radioiodine non-responsive disease. Semin Surg Oncol. 1999; 16(1):34-41. DOI: 10.1002/(sici)1098-2388(199901/02)16:1<34::aid-ssu7>3.0.co;2-2. View

Xu X, Lai Y, Hua Z . Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2018; 39(1). PMC: 6340950. DOI: 10.1042/BSR20180992. View

Guschin D, Rogers N, Briscoe J, Witthuhn B, Watling D, Horn F . A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J. 1995; 14(7):1421-9. PMC: 398228. DOI: 10.1002/j.1460-2075.1995.tb07128.x. View

Yore M, Liby K, Honda T, Gribble G, Sporn M . The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase beta. Mol Cancer Ther. 2006; 5(12):3232-9. DOI: 10.1158/1535-7163.MCT-06-0444. View

Alpajaro S, Harris J, Evans C . Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapies. Prostate Cancer Prostatic Dis. 2018; 22(1):16-23. DOI: 10.1038/s41391-018-0078-1. View

Siddiquee K, Turkson J . STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res. 2008; 18(2):254-67. PMC: 2610254. DOI: 10.1038/cr.2008.18. View

Yuen J, Gohel M . Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer. 2005; 53(1):11-7. DOI: 10.1207/s15327914nc5301_2. View

Ai T, Wang Z, Zhang M, Zhang L, Wang N, Li W . Expression and prognostic relevance of STAT3 and cyclin D1 in non-small cell lung cancer. Int J Biol Markers. 2012; 27(2):e132-8. DOI: 10.5301/JBM.2012.9146. View

Gurbuz V, Konac E, Varol N, Yilmaz A, Gurocak S, Menevse S . Effects of AG490 and S3I-201 on regulation of the JAK/STAT3 signaling pathway in relation to angiogenesis in TRAIL-resistant prostate cancer cells . Oncol Lett. 2014; 7(3):755-763. PMC: 3919920. DOI: 10.3892/ol.2014.1795. View

10.

Pilati C, Amessou M, Bihl M, Balabaud C, Tran Van Nhieu J, Paradis V . Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med. 2011; 208(7):1359-66. PMC: 3135371. DOI: 10.1084/jem.20110283. View

11.

Pilling A, Hwang C . Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide. Prostate. 2019; 79(11):1347-1359. PMC: 6617752. DOI: 10.1002/pros.23843. View

12.

Chen Y, Wang J, Wang X, Liu X, Li H, Lv Q . STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer. J Breast Cancer. 2013; 16(1):40-9. PMC: 3625768. DOI: 10.4048/jbc.2013.16.1.40. View

13.

Sun X, Liao Y, Li W, Guo L . Neuroprotective effects of polysaccharides against oxidative stress-induced neuronal apoptosis. Neural Regen Res. 2017; 12(6):953-958. PMC: 5514871. DOI: 10.4103/1673-5374.208590. View

14.

Sliva D . Cellular and physiological effects of Ganoderma lucidum (Reishi). Mini Rev Med Chem. 2004; 4(8):873-9. DOI: 10.2174/1389557043403323. View

15.

Lewis M, Kasper J, Bazil J, Frisbee J, Wiseman R . Quantification of Mitochondrial Oxidative Phosphorylation in Metabolic Disease: Application to Type 2 Diabetes. Int J Mol Sci. 2019; 20(21). PMC: 6862501. DOI: 10.3390/ijms20215271. View

16.

Rawla P . Epidemiology of Prostate Cancer. World J Oncol. 2019; 10(2):63-89. PMC: 6497009. DOI: 10.14740/wjon1191. View

17.

Lee C, Cheung S . STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma. Cancers (Basel). 2019; 11(11). PMC: 6895841. DOI: 10.3390/cancers11111646. View

18.

Martinez-Montemayor M, Acevedo R, Otero-Franqui E, Cubano L, Dharmawardhane S . Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer. Nutr Cancer. 2011; 63(7):1085-94. PMC: 3201987. DOI: 10.1080/01635581.2011.601845. View

19.

Bhosale G, Duchen M . Investigating the Mitochondrial Permeability Transition Pore in Disease Phenotypes and Drug Screening. Curr Protoc Pharmacol. 2019; 85(1):e59. PMC: 9286464. DOI: 10.1002/cpph.59. View

20.

Slivova V, Zaloga G, DeMichele S, Mukerji P, Huang Y, Siddiqui R . Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells. Nutr Cancer. 2005; 52(1):66-73. DOI: 10.1207/s15327914nc5201_9. View